Arovella Therapeutics Limited (ASX:ALA)

Arovella Therapeutics Statistics

Total Valuation

ASX:ALA has a market cap or net worth of AUD 124.80 million. The enterprise value is 113.05 million.

Market Cap	124.80M
Enterprise Value	113.05M

Important Dates

The next estimated earnings date is Thursday, August 21, 2025.

Earnings Date	Aug 21, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:ALA has 1.19 billion shares outstanding. The number of shares has increased by 23.23% in one year.

Current Share Class	1.19B
Shares Outstanding	1.19B
Shares Change (YoY)	+23.23%
Shares Change (QoQ)	+7.33%
Owned by Insiders (%)	14.24%
Owned by Institutions (%)	10.08%
Float	894.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	36.20
PB Ratio	10.81
P/TBV Ratio	10.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-18.05
EV / Sales	32.79
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-17.28

Financial Position

The company has a current ratio of 11.24

Current Ratio	11.24
Quick Ratio	10.82
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -85.35% and return on invested capital (ROIC) is -55.88%.

Return on Equity (ROE)	-85.35%
Return on Assets (ROA)	-45.61%
Return on Invested Capital (ROIC)	-55.88%
Return on Capital Employed (ROCE)	-56.73%
Revenue Per Employee	127,695
Profits Per Employee	-231,920
Employee Count	27
Asset Turnover	0.38
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.36% in the last 52 weeks. The beta is -0.08, so ASX:ALA's price volatility has been lower than the market average.

Beta (5Y)	-0.08
52-Week Price Change	-36.36%
50-Day Moving Average	0.09
200-Day Moving Average	0.13
Relative Strength Index (RSI)	53.69
Average Volume (20 Days)	1,287,552

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:ALA had revenue of AUD 3.45 million and -6.26 million in losses. Loss per share was -0.01.

Revenue	3.45M
Gross Profit	3.45M
Operating Income	-6.56M
Pretax Income	-6.26M
Net Income	-6.26M
EBITDA	-6.49M
EBIT	-6.56M
Loss Per Share	-0.01

Balance Sheet

The company has 11.75 million in cash and n/a in debt, giving a net cash position of 11.75 million or 0.01 per share.

Cash & Cash Equivalents	11.75M
Total Debt	n/a
Net Cash	11.75M
Net Cash Per Share	0.01
Equity (Book Value)	11.54M
Book Value Per Share	0.01
Working Capital	11.12M

Cash Flow

In the last 12 months, operating cash flow was -6.09 million and capital expenditures -453,801, giving a free cash flow of -6.54 million.

Operating Cash Flow	-6.09M
Capital Expenditures	-453,801
Free Cash Flow	-6.54M
FCF Per Share	-0.01

Margins

Gross margin is 100.00%, with operating and profit margins of -190.25% and -181.62%.

Gross Margin	100.00%
Operating Margin	-190.25%
Pretax Margin	-181.62%
Profit Margin	-181.62%
EBITDA Margin	-188.25%
EBIT Margin	-190.25%
FCF Margin	n/a

Dividends & Yields

ASX:ALA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.23%
Shareholder Yield	n/a
Earnings Yield	-5.02%
FCF Yield	-5.24%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 14, 2019. It was a reverse split with a ratio of 0.04.

Last Split Date	Nov 14, 2019
Split Type	Reverse
Split Ratio	0.04

Scores

ASX:ALA has an Altman Z-Score of 72.39 and a Piotroski F-Score of 4.

Altman Z-Score	72.39
Piotroski F-Score	4